Literature DB >> 1514036

Serum interleukin (IL-1 beta) in patients with diffuse scleritis.

G N Palexas1, A Puren, N Savage, N H Welsh.   

Abstract

Scleritis is a painful, destructive inflammatory eye disease. We measured serum IL-1 beta in ten patients with diffuse scleritis and in control subjects matched for age and sex. Patients with diffuse scleritis were found to have significantly elevated serum concentrations of IL-1 beta in comparison to normal subjects (P less than 0.02). The results suggest that IL-1 beta is associated with diffuse scleritis and may influence scleral breakdown in diffuse scleritis.

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1514036     DOI： 10.1111/j.1365-3083.1992.tb01644.x

Source DB:  PubMed          Journal:  Scand J Immunol Suppl        ISSN： 0301-6323


  4 in total

1.  Advances in Disease Mechanisms and Translational Technologies: Clinicopathologic Significance of Inflammasome Activation in Autoimmune Diseases.

Authors:  J Michelle Kahlenberg; Insoo Kang
Journal:  Arthritis Rheumatol       Date:  2020-01-15       Impact factor: 10.995

2.  Gevokizumab in the Treatment of Autoimmune Non-necrotizing Anterior Scleritis: Results of a Phase I/II Clinical Trial.

Authors:  Jared E Knickelbein; William R Tucker; Nirali Bhatt; Karen Armbrust; David Valent; Dominic Obiyor; Robert B Nussenblatt; H Nida Sen
Journal:  Am J Ophthalmol       Date:  2016-09-20       Impact factor: 5.258

3.  Circulating cytokine concentrations and cytokine production by monocytes from newborn babies and adults.

Authors:  V Pillay; N Savage; H Laburn
Journal:  Pflugers Arch       Date:  1994-10       Impact factor: 3.657

4.  Bilateral anterior and posterior scleritis in a patient with acute myelogenous leukemia.

Authors:  Pujan R Patel; Maureen C Farrell; Ani Peshtani; Meghan K Berkenstock
Journal:  Am J Ophthalmol Case Rep       Date:  2022-03-24
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.